Evidence map›Paper›PMID 40077188›Full record

ArticleMaterials (Basel, Switzerland)2025

Construction of Antibacterial MoS

Mengxin Mao, Diyi Li, Yunyun Wu, Bing Li, Xiaoqing Han, Jiao Yan, Lei Shang, Haiyuan Zhang, Xi Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Caerin 1.1/1.9 peptides controlFrontiers in microbiology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengxin MaoSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.
Diyi LiSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.
Yunyun WuSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.
Bing LiSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.
Xiaoqing HanLaboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Jiao YanLaboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Lei ShangSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.
Haiyuan ZhangLaboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Xi LiSchool of Chemistry and Life Science, Changchun University of Technology, Changchun 130012, China.

Funding

National Key R&D Program of China 2021YFF0704805National Natural Science Foundation of China 22007087
6 · The paper itself

Abstract

The transition between the inflammatory phase and the proliferative phase is critical for wound healing. However, the development of proper switchers that can regulate this transition is facing great challenges. Macrophages play versatile roles in all wound healing phases because they can readily switch from pro-inflammatory M1 phenotypes to anti-inflammatory M2 phenotypes in response to different microenvironment stimuli. Herein, taking advantage of enhanced electron transfer by coupling MoS

Indexed as

bidirectional regulationinflammation–proliferation transitionmacrophage reprogrammingMoS2-activated carbon fiber materialswound healing

Identifiers

PMID40077188
PMCPMC11901119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.